# Evaluation of Early CRRT InTerventions in Patients With ECMO(ELITE)

Study · id `cardio:ct-nct03549923` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03549923](<https://clinicaltrials.gov/study/NCT03549923>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03549923

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 131 participants.

## Technical summary

Registry record NCT03549923. Randomized; no masking; primary purpose treatment. Start 2018-12-18 (actual); primary completion 2022-10-22 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 131 participants (enrolled count; ClinicalTrials.gov record NCT03549923, source copy `cardio:ctgov-nct03549923-2024-04-24`, retrieved 2026-10-31)
- Started: 2018-12-18 (actual) (ClinicalTrials.gov record NCT03549923, source copy `cardio:ctgov-nct03549923-2024-04-24`, retrieved 2026-10-31)
- Primary completion: 2022-10-22 (actual) (ClinicalTrials.gov record NCT03549923, source copy `cardio:ctgov-nct03549923-2024-04-24`, retrieved 2026-10-31)
- Completion: 2023-05-01 (actual) (ClinicalTrials.gov record NCT03549923, source copy `cardio:ctgov-nct03549923-2024-04-24`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT03549923, source copy `cardio:ctgov-nct03549923-2024-04-24`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03549923-2024-04-24`, retrieved 2026-10-31)

## The registry's words

- Brief title: Evaluation of Early CRRT InTerventions in Patients With ECMO(ELITE)
- Acronym: ELITE
- Condition: Cardiogenic Shock
- Intervention (Device): Simultaneous CRRT
- Intervention (Device): Conventional-indication CRRT
- Intervention (Drug): Esmolol
- Intervention (Drug): Standard care
- Lead sponsor: Beijing Anzhen Hospital
- Lead sponsor class: OTHER
- Collaborator: The First Affiliated Hospital of Zhengzhou University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Cardiogenic shock (`cardio:cardiogenic-shock`)
- Registry lists this organization as the lead sponsor: Beijing Anzhen Hospital (`cardio:org-beijing-anzhen-hospital`)
- Registry lists this organization as a collaborator: The First Affiliated Hospital of Zhengzhou University (`cardio:org-the-first-affiliated-hospital-of-zhengzhou-university`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of early continuous renal replacement therapy in critically ill patients requiring ECMO treatment: results of a randomised controlled trial (`cardio:pubmed-42425722`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 7ba34760dd68348f1556e2f4840ae688845cef295867832dad695073e3164b88
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
